| Financial Year |
March 31 2023 |
| Monetary Funds |
21,838,183,752.61 |
| Held-for-trading Financial Assets |
1,400,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
2,037,967,801.22 |
| Advances to Suppliers |
562,366,589.92 |
| Other Receivables |
883,662,052.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
600,000,000.00 |
| Inventories |
1,308,702,520.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
188,496,319.96 |
| Other Current Assets |
514,249,802.98 |
| Total Current Assets |
28,733,628,839.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
389,816,447.36 |
| Long-term Equity Investment |
10,366,350,333.85 |
| Investment Properties |
390,704,154.00 |
| Fixed Assetes |
27,092,403,879.20 |
| Under-construction Projects |
6,715,890,236.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,272,726,810.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,973,077,111.09 |
| Deferred Income Tax Assets |
750,244,286.68 |
| Other Non-Current Assets |
703,419,296.99 |
| Sub-Total of Non-Current Assets |
63,182,098,433.67 |
| Total Assets |
91,915,727,273.20 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,675,001,702.90 |
| Accounts Payable |
2,329,938,691.21 |
| Accounts Received In Advance |
2,915,731.12 |
| Employee Compensation Payable |
173,823,541.35 |
| Taxes Payable |
1,038,436,783.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,060,447,452.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,853,260,896.78 |
| Other Current Liabilities |
86,866,549.58 |
| Sub-Total of Current Liabilities |
12,915,887,960.89 |
| Long-term Loans |
12,818,285,411.51 |
| Bonds Payable |
305,819,425.67 |
| Long-Term Accounts Payable |
998,084,341.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,453,533,435.96 |
| Deferred Income Tax Liabilities |
1,005,931,277.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,625,596,962.54 |
| Total Liabilities |
29,541,484,923.43 |
| Paid-In Capital(Or Share Stock) |
3,254,007,000.00 |
| Capital Surplus |
3,963,140,570.28 |
| Surplus Reserve |
1,634,024,476.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
41,356,827,496.51 |
| Minority Stockholder's Interest |
9,341,175,201.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
53,033,067,148.43 |
| Owner's Equity（Stockholder's Equity） |
62,374,242,349.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
91,915,727,273.20 |
